drugset / Trial / NCT00657020

Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms

NCT00657020

Phase 4 Completed 23 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindBasic science

Summary

A single center, double blind, randomized, placebo controlled, two-treatments, two-period crossover study conducted in adult smokers.

Timeline

Start
2007-09
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 4 mg Oral

Indications

No indication recorded.